TrademarkDir
BSRI
LIVE

Serial Number

85877839

Owner

International Myeloma Foundation

Attorney

Natasha Shabani

Filing Date

Mar 15, 2013

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

BSRI Trademark

Serial Number: 85877839 • Registration: 4421547

BSRI is a trademark filed by International Myeloma Foundation on March 15, 2013. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

International Myeloma Foundation (85 trademarks)

Suite 206
North Hollywood, CA 91607

Entity Type: 99

Trademark Details

Filing Date

March 15, 2013

Registration Date

October 22, 2013

Published for Opposition

August 6, 2013

Goods & Services

Medical research

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
May 11, 2023 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
May 11, 2023 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
May 11, 2023 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 11, 2023 APRE
TEAS SECTION 8 & 9 RECEIVED
Oct 26, 2022 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Oct 22, 2022 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Nov 24, 2018 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Nov 24, 2018 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 24, 2018 APRE
TEAS SECTION 8 & 15 RECEIVED
Nov 1, 2018 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 22, 2018 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 5, 2018 TCCA
REGISTERED-PRINCIPAL REGISTER
Oct 22, 2013 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 6, 2013 NPUB
PUBLISHED FOR OPPOSITION
Aug 6, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 17, 2013 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 24, 2013 CNSA
ASSIGNED TO EXAMINER
Jun 24, 2013 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Mar 22, 2013 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 21, 2013 NWOS
NEW APPLICATION ENTERED
Mar 19, 2013 NWAP

Related Trademarks

More from this Owner

IMPROVING LIVES ACCELERATING THE CURE

IMPROVING LIVES ACCELERATING THE CURE

IMF USMN

IMF USMN

IMF USMN

IMF USMN

IMF USMN

IMF USMN

USMN

USMN

USMN

USMN